634 AAK1 inhibitor LX-9211: Junctional protein 2-associated kinase 1 (AAK1) is widely expressed in the brain and spinal cord and is a viable target for the treatment of neuropathic pain, and BMS-986176/LX-9211 is a novel class of bis(iso)aryl ethers that are highly selective, CNS-permeable, and potent AAK1 inhibitors
It blends effortlessly with smoothies, shakes, juice, or water
It is a direct-acting, cell-remodeling and gene-modulating peptide
However, for general daily supplementation, capsules are equally effective
These symptoms generally improve by week 10-12 as the body adapts to maintenance dosing
He has co-authored 3 textbooks with 15 National and International Publications to his name